SOW
NRIX icon

State of Wyoming’s Nurix Therapeutics NRIX Stock Holding History

State of Wyoming’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-209
Closed -$3K – 1798
2022
Q2 		$3K Sell
209
-1,094
-84% -$12.4K ﹤0.01% 1760
2022
Q1 		$18K Buy
1,303
+422
+48% +$7.49K 0.01% 1467
2021
Q4 		$26K Buy
881
+119
+16% +$3.61K 0.01% 1408
2021
Q3 		$23K Sell
762
-459
-38% -$14.2K 0.01% 917
2021
Q2 		$32K Buy
1,221
+806
+194% +$23.7K 0.02% 848
2021
Q1 		$13K Buy
+415
New +$15.7K 0.02% 363

Other funds holding NRIX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State of Wyoming's NRIX Position: Q3 2022 in Review

State of Wyoming sold out of Nurix Therapeutics (NRIX) in Q3 2022, closing a stake of 209 shares — an estimated $3K sold.

State of Wyoming first reported a position in NRIX in Q1 2021 and held it in 6 quarters. The position peaked at $32K in Q2 2021. 118 funds tracked by Wall St. Rank hold NRIX as of Q3 2022.

  • State of Wyoming reported no remaining Nurix Therapeutics position as of Q3 2022 after selling out during the quarter.
  • State of Wyoming sold 209 Nurix Therapeutics shares in Q3 2022, an estimated $3K.
  • State of Wyoming first reported a position in Nurix Therapeutics in Q1 2021 and held it in 6 quarters.
  • State of Wyoming's Nurix Therapeutics position peaked at $32K in Q2 2021.
  • 118 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2022.

Based on State of Wyoming's 13F filing for Q3 2022, filed 14 Nov 2022.